Evaluation of a Chatbot With CALMO (Chatbot-Assisted Learning Model) to Enhance Clinical Learning in Nursing Students
CALMO
Development and Evaluation of a Chatbot With CALMO to Enhance Clinical Learning in Nursing Students: A Quasi-Experimental Mixed-Methods Study
1 other identifier
interventional
174
0 countries
N/A
Brief Summary
The present proposed study will design and develop a chatbot to support graduating nursing students' clinical learning. The efficacy of this chatbot technology will be evaluated, using a mixed methods quasi-experimental design. the proposed study hypothesizes that the chatbot-assisted clinical education has the potential to promote clinical performance by improving nursing knowledge, general self-efficacy, and self-reflection and insight.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2025
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 11, 2025
CompletedStudy Start
First participant enrolled
January 11, 2025
CompletedFirst Posted
Study publicly available on registry
January 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
January 17, 2025
January 1, 2025
1.7 years
January 11, 2025
January 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
nursing knowledge
multiple-choice questionnaire (MCQ) consisting of 50 items will be administered to evaluate students' nursing knowledge. the score ranges from 0 to 50. the higher the score, the better nursing knowledge.
before-intervention at baseline (T0), 4 weeks after baseline (week 4, T1) and after intervention (week 12; T2).
General self-efficacy
A 10-item General Self-Efficacy Scale to assess a general sense of perceived self-efficacy to manage hassles. It is scored with possible responses, 1=not at all true; 2=hardly true; 3=moderately true; and 4=exactly true, yielding a total score between 10 and 40. The higher the score, the higher the optimistic to cope with daily hassles.
before-intervention at baseline (T0), 4 weeks after baseline (week 4, T1) and after intervention (week 12; T2).
Secondary Outcomes (2)
Self-reflection and insight
: before-intervention at baseline (T0), 4 weeks after baseline (week 4, T1) and after intervention (week 12; T2).
Qualitative Comments on the Perceptions of Chatbot-assisted technology
at the end of the 12-week study
Study Arms (2)
Chatbot assisted learning
EXPERIMENTALThe participants will recevie a self-developed web-based chatbot platform which is accessible via smartphones. It provides real-time dialogue with the chatbot through texts, visual aids, and audio files. The intervention will be available throughout the 12-week study. the chatbot is characterized by a gender-neutral persona, assumes the role of a friendly and empathetic clinical mentor. Its communication style can be described as calm, tolerant, supportive, and appreciative. Participants will receive weekly Short Message Service (SMS) notifications to remind them to consult with the chatbot.
control group _usual care
NO INTERVENTIONParticipants in the Control Group will receive their usual clinical education support during the intervention period
Interventions
The participants will recevie a self-developed web-based chatbot platform which is accessible via smartphones. It provides real-time dialogue with the chatbot through texts, visual aids, and audio files. The intervention will be available throughout the 12-week study. the chatbot is characterized by a gender-neutral persona, assumes the role of a friendly and empathetic clinical mentor. Its communication style can be described as calm, tolerant, supportive, and appreciative. Participants will receive weekly SMS notifications to remind them to consult with the chatbot.
Eligibility Criteria
You may qualify if:
- Baccalaureate nursing students participating in their final clinical placement
- have sufficient knowledge of English language
- own a smartphone with internet access
- possess a valid Hong Kong phone number
- possess a valid email address
You may not qualify if:
- those who have been involved in the pilot test of the proposed chatbot intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Caritas Institute of Higher Educationlead
- Tung Wah Collegecollaborator
Study Officials
- PRINCIPAL INVESTIGATOR
Winnie LS CHENG, PhD
Saint Francis University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- In this study, outcome assessors were effectively blinded to participant group assignments through the use of an advanced electronic data collection platform. Each participant was assigned a unique identifier by the system, which masked their group allocation. Assessors accessed participant data through a secure portal that only displayed these identifiers and relevant clinical data, without any indication of group membership.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 11, 2025
First Posted
January 17, 2025
Study Start
January 11, 2025
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
January 17, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
I will not publish in Medical Journal Editors